Bulletin from the extraordinary general meeting in Boule Diagnostics on November 1, 2022
Boule Diagnostics – Nomination Committee for the 2023 Annual General Meeting
Boule sets up contract manufacturing of reagents in India
Boule Diagnostics resolves on a fully secured preferential rights issue of approximately SEK 150 million
Clinical Diagnostic Solutions has been issued a Notice of Inspectional Observations by FDA
CFO Annette Colin leaves Boule due to family reasons
Boule Diagnostics (publ) Interim report January–June 2022
Boule Diagnostics – Invitation to presentation of the interim report Q2 2022
Bulletin from Annual General Meeting in Boule Diagnostics AB on May 5, 2022
Boule Diagnostics (publ) Interim report January–March 2022
Cision will store the added information in order to continuously be able to send you the information you’ve chosen to subscribe to. Read more about how Cision process personal data.
Search
Search on the page